These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26064792)

  • 1. Hypoascorbemia induces atherosclerosis and vascular deposition of lipoprotein(a) in transgenic mice.
    Cha J; Niedzwiecki A; Rath M
    Am J Cardiovasc Dis; 2015; 5(1):53-62. PubMed ID: 26064792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein(a) and vitamin C impair development of breast cancer tumors in Lp(a)+; Gulo-/- mice.
    Cha J; Roomi MW; Kalinovsky T; Niedzwiecki A; Rath M
    Int J Oncol; 2016 Sep; 49(3):895-902. PubMed ID: 27573077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological evidence for the accumulation of lipoprotein(a) in the atherosclerotic lesion of the hypoascorbemic guinea pig.
    Rath M; Pauling L
    Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9388-90. PubMed ID: 2147514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age and Dietary Vitamin C Intake Affect Brain Physiology in Genetically Modified Mice Expressing Human Lipoprotein(A) and Unable to Synthesize Vitamin C.
    Shi L; Niedzwiecki A; Rath M
    Curr Aging Sci; 2021; 14(3):223-234. PubMed ID: 34229598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental Animal Models Evaluating the Causal Role of Lipoprotein(a) in Atherosclerosis and Aortic Stenosis.
    Yeang C; Cotter B; Tsimikas S
    Cardiovasc Drugs Ther; 2016 Feb; 30(1):75-85. PubMed ID: 26780907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New data about lipoprotein(a): a curious molecule or a causal cardiovascular risk factor?].
    de Brouckère V; Liénart F; Ducobu J
    Rev Med Brux; 2010; 31(3):171-6. PubMed ID: 20687444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lipoprotein Lp(a) and CETP (cholesterol ester transfer protein): contribution of transgenic mice].
    Chapman J; Guérin M
    Bull Acad Natl Med; 1994 Mar; 178(3):427-34; discussion 434-6. PubMed ID: 8076182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel insights into Lp(a) physiology and pathogenicity: more questions than answers?
    Koschinsky ML
    Cardiovasc Hematol Disord Drug Targets; 2006 Dec; 6(4):267-78. PubMed ID: 17378772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein apheresis is an optimal therapeutic option to reduce increased Lp(a) levels.
    Schettler VJJ; Neumann CL; Peter C; Zimmermann T; Julius U; Hohenstein B; Roeseler E; Heigl F; Grützmacher P; Blume H; Klingel R; Vogt A;
    Clin Res Cardiol Suppl; 2019 Apr; 14(Suppl 1):33-38. PubMed ID: 30838552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma carboxyl ester lipase activity modulates apolipoprotein B-containing lipoprotein metabolism in a transgenic mouse model.
    Li L; Weng W; Harrison EH; Fisher EA
    Metabolism; 2008 Oct; 57(10):1361-8. PubMed ID: 18803939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models.
    Boffa MB; Marcovina SM; Koschinsky ML
    Clin Biochem; 2004 May; 37(5):333-43. PubMed ID: 15087247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
    Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
    Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma.
    Tellis CC; Tselepis AD
    Biochim Biophys Acta; 2009 May; 1791(5):327-38. PubMed ID: 19272461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extraction of lipoprotein(a), apo B, and apo E from fresh human arterial wall and atherosclerotic plaques.
    Reblin T; Meyer N; Labeur C; Henne-Bruns D; Beisiegel U
    Atherosclerosis; 1995 Mar; 113(2):179-88. PubMed ID: 7605357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein(a) - Link between Atherogenesis and Thrombosis.
    Labudovic D; Kostovska I; Tosheska Trajkovska K; Cekovska S; Brezovska Kavrakova J; Topuzovska S
    Prague Med Rep; 2019; 120(2-3):39-51. PubMed ID: 31586503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for the pathophysiology of lipoprotein(a) in the athero-thrombotic process.
    Anglés-Cano E
    Braz J Med Biol Res; 1997 Nov; 30(11):1271-80. PubMed ID: 9532233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lp(a) (Lipoprotein(a)) Levels Predict Progression of Carotid Atherosclerosis in Subjects With Atherosclerotic Cardiovascular Disease on Intensive Lipid Therapy: An Analysis of the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) Carotid Magnetic Resonance Imaging Substudy-Brief Report.
    Hippe DS; Phan BAP; Sun J; Isquith DA; O'Brien KD; Crouse JR; Anderson T; Huston J; Marcovina SM; Hatsukami TS; Yuan C; Zhao XQ
    Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):673-678. PubMed ID: 29301785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein(a) and atherosclerosis.
    Scanu AM; Lawn RM; Berg K
    Ann Intern Med; 1991 Aug; 115(3):209-18. PubMed ID: 1829339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
    Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic rabbits expressing human apolipoprotein (a).
    Fan J; Watanabe T
    J Atheroscler Thromb; 2000; 7(1):8-13. PubMed ID: 11425047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.